The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Amgen; Amgen; Amgen; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Ipsen; Ipsen; Ipsen; Ipsen; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
Consulting or Advisory Role - Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Prestizia; Prestizia; Prestizia; Prestizia
Research Funding - Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis
Role of precision medicine for patients with advanced biliary tract cancers.
 
Antoine Hollebecque
Honoraria - Merck Serono; Merck Serono; Merck Serono; Merck Serono
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Gritstone Bio; Gritstone Bio; Gritstone Bio; Gritstone Bio; Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Spectrum Pharmaceuticals (Inst); Spectrum Pharmaceuticals (Inst); Spectrum Pharmaceuticals (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Lilly; Lilly; Lilly; Lilly; SERVIER; SERVIER; SERVIER; SERVIER
Other Relationship - Abbvie; Abbvie; Abbvie; Abbvie; Agios; Agios; Agios; Agios; Amgen; Amgen; Amgen; Amgen; argenx; argenx; argenx; argenx; Arno Therapeutics; Arno Therapeutics; Arno Therapeutics; Arno Therapeutics; Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; Astex Pharmaceuticals; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AVEO; AVEO; AVEO; AVEO; Bayer; Bayer; Bayer; Bayer; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Clovis Oncology; Clovis Oncology; Clovis Oncology; Clovis Oncology; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Debiopharm Group; Debiopharm Group; Debiopharm Group; Debiopharm Group; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; FORMA Therapeutics; FORMA Therapeutics; FORMA Therapeutics; FORMA Therapeutics; GamaMabs Pharma; GamaMabs Pharma; GamaMabs Pharma; GamaMabs Pharma; Genentech; Genentech; Genentech; Genentech; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; Innate Pharma; Innate Pharma; Innate Pharma; Innate Pharma; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Janssen-Cilag; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Kyowa Hakko Kirin; Lilly; Lilly; Lilly; Lilly; Loxo; Loxo; Loxo; Loxo; Lytix Biopharma; Lytix Biopharma; Lytix Biopharma; Lytix Biopharma; MedImmune; MedImmune; MedImmune; MedImmune; Menarini; Menarini; Menarini; Menarini; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merrimack; Merrimack; Merrimack; Merrimack; Merus; Merus; Merus; Merus; Millenium Pharamceuticals; Millenium Pharamceuticals; Millenium Pharamceuticals; Millenium Pharamceuticals; Nanobiotix; Nanobiotix; Nanobiotix; Nanobiotix; Nektar; Nektar; Nektar; Nektar; Novartis; Novartis; Novartis; Novartis; Octimet; Octimet; Octimet; Octimet; Oncoethix; Oncoethix; Oncoethix; Oncoethix; Onyx; Onyx; Onyx; Onyx; Orion; Orion; Orion; Orion; Oryzon Genomics; Oryzon Genomics; Oryzon Genomics; Oryzon Genomics; Pfizer; Pfizer; Pfizer; Pfizer; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Roche; Roche; Roche; Roche; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; SERVIER; SERVIER; SERVIER; SERVIER; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Tesaro; Tesaro; Tesaro; Tesaro; Xencor; Xencor; Xencor; Xencor
 
Oumrou Nabi
No Relationships to Disclose
 
Michel Ducreux
Employment - Sandoz (I); Sandoz (I); Sandoz (I); Sandoz (I)
Honoraria - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Novartis; Novartis; Novartis; Novartis; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Servier; Servier; Servier; Servier
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche; Servier; Servier; Servier; Servier
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Roche; Roche; Roche; Roche
Research Funding - Keocyt (Inst); Keocyt (Inst); Keocyt (Inst); Keocyt (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Ipsen; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche
 
Valerie Boige
No Relationships to Disclose
 
Jean-Yves Scoazec
No Relationships to Disclose
 
Etienne Rouleau
No Relationships to Disclose
 
Alice Boileve
No Relationships to Disclose
 
Cristina Smolenschi
No Relationships to Disclose
 
Loic Verlingue
No Relationships to Disclose
 
Margarida Matias
No Relationships to Disclose
 
Pascal Burtin
No Relationships to Disclose
 
Caroline Prieux-Klotz
No Relationships to Disclose
 
Christophe Massard
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; BeiGene; BeiGene; BeiGene; BeiGene; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Debiopharm Group; Debiopharm Group; Debiopharm Group; Debiopharm Group; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; INNATE PHARMA; INNATE PHARMA; INNATE PHARMA; INNATE PHARMA; IPSEN; IPSEN; IPSEN; IPSEN; Janssen; Janssen; Janssen; Janssen; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Orion; Orion; Orion; Orion; Pfizer; Pfizer; Pfizer; Pfizer; PharmaMar; PharmaMar; PharmaMar; PharmaMar; Sanofi; Sanofi; Sanofi; Sanofi; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
 
David Malka
Honoraria - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; HalioDx; HalioDx; HalioDx; HalioDx; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Pierre Fabre; Pierre Fabre; Pierre Fabre; Pierre Fabre; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Baxalta; Baxalta; Baxalta; Baxalta; Bayer; Bayer; Bayer; Bayer; HalioDx; HalioDx; HalioDx; HalioDx; Incyte; Incyte; Incyte; Incyte; Merck Serono; Merck Serono; Merck Serono; Merck Serono; MSD; MSD; MSD; MSD; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; SERVIER; SERVIER; SERVIER; SERVIER
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi